Breast cancer experts have urged Pharmac to fast-track the drug Keytruda, for Kiwis with an aggressive form of breast cancer. The drug is used to treat triple-negative breast cancer (TNBC), and ...

Merck (MRK) stock trended lower as Halozyme (HALO) challenges the company over injectable Keytruda patents. Read more here.

In extending patent protection for its primary cancer medication, Keytruda, Merck (NYSE:MRK) intends to introduce a subcutaneous form of it this year. It's important to also note that Merck is getting ...